The cycle of human herpes simplex virus infection: virus transport and immune control.
about
HSV-2: in pursuit of a vaccineUnderstanding natural herpes simplex virus immunity to inform next-generation vaccine designTissue-resident memory T cellsImmunological aspects of acute and recurrent herpes simplex keratitisOcular herpes simplex virus: how are latency, reactivation, recurrent disease and therapy interrelated?The challenges and opportunities for the development of a T-cell epitope-based herpes simplex vaccineGenital Herpes: Insights into Sexually Transmitted Infectious DiseaseImmunobiology of herpes simplex virus and cytomegalovirus infections of the fetus and newbornAn attenuated herpes simplex virus type 1 (HSV1) encoding the HIV-1 Tat protein protects mice from a deadly mucosal HSV1 challengeCurrent status and prospects for development of an HSV vaccineThe association of viral proteins with host cell dynein components during virus infection.Herpes simplex virus type-2 stimulates HIV-1 replication in cervical tissues: implications for HIV-1 transmission and efficacy of anti-HIV-1 microbicidesHigh-purity preparation of HSV-2 vaccine candidate ACAM529 is immunogenic and efficacious in vivoRapid clearance of herpes simplex virus type 2 by CD8+ T cells requires high level expression of effector T cell functionsSOCS1/3 expression levels in HSV-1-infected, cytokine-polarized and -unpolarized macrophagesA systematic analysis of host factors reveals a Med23-interferon-λ regulatory axis against herpes simplex virus type 1 replication.Macrophage-mediated optic neuritis induced by retrograde axonal transport of spike gene recombinant mouse hepatitis virusRelay of herpes simplex virus between Langerhans cells and dermal dendritic cells in human skin.Activation of NF-κB in CD8+ dendritic cells Ex Vivo by the γ134.5 null mutant correlates with immunity against herpes simplex virus 1.Therapeutic immunization with a mixture of herpes simplex virus 1 glycoprotein D-derived “asymptomatic” human CD8+ T-cell epitopes decreases spontaneous ocular shedding in latently infected HLA transgenic rabbits: association with low frequency of lImmunodominant epitopes in herpes simplex virus type 2 glycoprotein D are recognized by CD4 lymphocytes from both HSV-1 and HSV-2 seropositive subjects.SR-2P vaginal microbicide gel provides protection against herpes simplex virus 2 when administered as a combined prophylactic and postexposure therapeuticControl of viral latency in neurons by axonal mTOR signaling and the 4E-BP translation repressor.HSV, axonal transport and Alzheimer's disease: in vitro and in vivo evidence for causal relationships.The Herpes Simplex Virus Latency-Associated Transcript Gene Is Associated with a Broader Repertoire of Virus-Specific Exhausted CD8+ T Cells Retained within the Trigeminal Ganglia of Latently Infected HLA Transgenic RabbitsAn adjuvanted herpes simplex virus 2 subunit vaccine elicits a T cell response in mice and is an effective therapeutic vaccine in Guinea pigs.Gender-dependent HLA-DR-restricted epitopes identified from herpes simplex virus type 1 glycoprotein D.Natural killer cell functional defects in pediatric patients with severe and recurrent herpesvirus infectionsAntiviral activity of trappin-2 and elafin in vitro and in vivo against genital herpes.In Situ Detection of Regulatory T Cells in Human Genital Herpes Simplex Virus Type 2 (HSV-2) Reactivation and Their Influence on Spontaneous HSV-2 ReactivationA novel HLA (HLA-A*0201) transgenic rabbit model for preclinical evaluation of human CD8+ T cell epitope-based vaccines against ocular herpes.Ocular HSV-1 latency, reactivation and recurrent disease.Does chronic stress lead to increased rates of recurrences of genital herpes--a review of the psychoneuroimmunological evidence?HSV-1-induced SOCS-1 expression in keratinocytes: use of a SOCS-1 antagonist to block a novel mechanism of viral immune evasionType I IFN response to Papiine herpesvirus 2 (Herpesvirus papio 2; HVP2) determines neuropathogenicity in mice.New concepts in herpes simplex virus vaccine development: notes from the battlefield.Nasal Immunization Confers High Avidity Neutralizing Antibody Response and Immunity to Primary and Recurrent Genital Herpes in Guinea Pigs.Defense against HSV-1 in a murine model is mediated by iNOS and orchestrated by the activation of TLR2 and TLR9 in trigeminal ganglia.Recognition of herpes simplex viruses: toll-like receptors and beyondAn Engineered Herpesvirus Activates Dendritic Cells and Induces Protective Immunity.
P2860
Q22306291-BE8A8AEF-AE9C-4D47-903E-014E1132B2EFQ26741484-04215D7F-66D8-48B8-9F6B-181E0E799E98Q26829804-CB5F7BED-C4D8-4AB2-869C-67E394A946C4Q27016103-53FC977F-21EA-4F7B-A317-513F656FC11DQ27021069-78388837-61F3-454B-864D-0318077D7ED0Q27021292-6BEE26EF-69E2-45AB-805E-4FA098747356Q30235026-BA9E783F-A6B6-4367-99CC-E8AB496074C1Q33835386-F75D3352-CBD7-484C-B987-BCCAF3A00729Q33916162-1088783E-906F-401B-938A-49AABA438CD1Q33931016-7BEF57A2-266A-455E-938D-BD07167ACA9DQ33967271-B7D1B6BB-C615-477F-A073-7A5119915018Q34064986-B2C4EEE5-E611-4149-AB85-BA3B7651FC63Q34331569-4F8DA733-FAF6-4C8E-944C-1EAF2155244BQ34850941-576617BD-E61E-47F3-B860-30548F691E4FQ34920297-5B67DABA-2D56-42A0-8B1A-F7CE27A3FECDQ34945388-AD4954C5-1DD2-42EE-96B5-BEC573B1B253Q35033339-0A13813E-60E7-4E2E-AED1-DF6072018533Q35602225-6DDAD4DD-E89B-4E4F-91B7-E53498F69B41Q35665813-DA20BF23-DC7D-439B-AAF9-592EFE36E14EQ35745358-1DA622A6-8C29-4ED4-919C-4E390E07CFC3Q35854117-D7E3C0A0-3DE4-4918-AC35-1A8929644D76Q35960877-84865AB9-E6FA-4D8F-BDDB-9C76E1C0BAA0Q36114081-1B18DF5C-8838-4FF7-B55F-9714594EF84FQ36537841-0C357B11-DC58-437A-A931-DA735C4051E6Q36736366-8287ADFB-50A7-4B5E-8D7A-1E293A036BB4Q36759693-BD32E0C5-8DBA-4CC3-B9A7-D312599BEB49Q36898071-4FC0E9F2-76AD-4040-B6FB-ED5E4B7DC394Q36957244-B30A3D8F-71C3-4D36-A4B7-1B52CBCEF50BQ36978882-46D38411-13C7-4646-95A1-82042F2A9137Q37003054-A108E577-9E4E-48A8-8D2D-64CC9C70F75AQ37118262-83EC2870-A3DC-4E26-98C1-BB6E3A7B185CQ37201603-34992092-D049-4F79-9255-59292D678626Q37205428-EB09DCA5-FC5D-4D33-985A-D6F51101C9E9Q37253362-C85B04B4-B949-44A5-A42A-79F1E086D335Q37311931-405DFBA1-E696-4766-BF4D-C4F533484D7FQ37384857-D145360E-D14C-4ED2-AC4C-27BFFC7CD1C6Q37531713-97BAE425-B5F7-4B48-B97D-6D86F6BDF12FQ37579649-021381FB-E66F-4139-8A25-5967A0901B1BQ37619828-C370DF59-4506-4373-95C4-1E105DBB22A5Q37620494-2E5C341E-F792-4C49-B01E-F2C0607ECBE8
P2860
The cycle of human herpes simplex virus infection: virus transport and immune control.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
The cycle of human herpes simplex virus infection: virus transport and immune control.
@ast
The cycle of human herpes simplex virus infection: virus transport and immune control.
@en
type
label
The cycle of human herpes simplex virus infection: virus transport and immune control.
@ast
The cycle of human herpes simplex virus infection: virus transport and immune control.
@en
prefLabel
The cycle of human herpes simplex virus infection: virus transport and immune control.
@ast
The cycle of human herpes simplex virus infection: virus transport and immune control.
@en
P2093
P2860
P356
P1476
The cycle of human herpes simplex virus infection: virus transport and immune control.
@en
P2093
Anthony L Cunningham
Cheryl Jones
Lidija Bosnjak
Mark W Douglas
Monica Miranda-Saksena
Russell J Diefenbach
P2860
P356
10.1086/505359
P407
P478
194 Suppl 1
P577
2006-09-01T00:00:00Z